Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Conference News AHA 2016

Intravenous Iron, Not Oral, Improves Functional Capacity in HF Patients

Michael O'Riordan

November 16, 2016

News Conference News AHA 2016

Early Vasodilator Therapy Not the Answer for Improving Long-term Outcomes After Acute Decompensated Heart Failure

Todd Neale

November 13, 2016

News Daily News

High-Intensity Statin Therapy Offers Survival Benefit Over Moderate-Intensity Statins in CVD Patients

Michael O'Riordan

November 10, 2016

Presentation TCT 2016

Personalized Medicine Where Are We in 2016?

Presenter: Robert A. Harrington, A. Michael Lincoff, Clyde W. Yancy

October 30, 2016

Presentation TCT 2016

Heart Failure Advances (Ivabradine, ARNI, and More)

Presenter: Robert A. Harrington, A. Michael Lincoff, Clyde W. Yancy

October 30, 2016

News Daily News

心血管药物发展趋势存在渠道问题和可能性

Caitlin E. Cox

September 08, 2016

News Daily News

Trends in Cardiovascular Drug Development Speak to Pipeline Problems and Possibilities

Caitlin E. Cox

September 08, 2016

News Daily News

Las Tendencias en el Desarrollo de Fármacos Cardiovasculares Indican Problemas y Posibilidades Durante la Fase de Desarrollo

Caitlin E. Cox

September 08, 2016

News Daily News

美国和欧洲的心衰指南提倡使用两个新疗法

L.A. McKeown

May 24, 2016

News Daily News

US and European Heart Failure Guidelines Advocate Use of Two New Therapies Las Directrices Europeas y Norteamericanas sobre Insuficiencia Cardíaca Abogan por el Uso de 2 Nuevos Tratamientos

L.A. McKeown

May 24, 2016

News Daily News

US and European Heart Failure Guidelines Advocate Use of Two New Therapies

L.A. McKeown

May 24, 2016

News Conference News ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Shelley Wood

April 08, 2016

News Conference News ACC 2016

Vagus Nerve Stimulation Fails to Improve Clinical Outcomes in Chronic Heart Failure

Todd Neale

April 05, 2016

News Daily News

Heart Failure Still a Problem but Less of a Burden on Acute MI Patients

Todd Neale

March 11, 2015

News Daily News

黑人NSTEMI患者的长期死亡率比白人患者差，这与治疗差异有关系

July 17, 2014

News Daily News

Long-term Mortality Worse for Black vs White NSTEMI Patients, Linked with Treatment Discrepancies

July 17, 2014

News Daily News

La Mortalidad a Largo Plazo es Peor en Pacientes NSTEMI de Raza Negra que en Pacientes de Raza Blanca con Discrepancias en el Tratamiento

July 17, 2014

News Industry News

Landmark IMPROVE HF Trial Shows Evidence-Based Programs Result in Improvements in Heart Failure Patients Regardless of Race, and Improves Survival

August 30, 2012

Advertisement

Intravenous Iron, Not Oral, Improves Functional Capacity in HF Patients

Early Vasodilator Therapy Not the Answer for Improving Long-term Outcomes After Acute Decompensated Heart Failure

High-Intensity Statin Therapy Offers Survival Benefit Over Moderate-Intensity Statins in CVD Patients

Personalized Medicine Where Are We in 2016?

Heart Failure Advances (Ivabradine, ARNI, and More)

心血管药物发展趋势存在渠道问题和可能性

Trends in Cardiovascular Drug Development Speak to Pipeline Problems and Possibilities

Las Tendencias en el Desarrollo de Fármacos Cardiovasculares Indican Problemas y Posibilidades Durante la Fase de Desarrollo

美国和欧洲的心衰指南提倡使用两个新疗法

US and European Heart Failure Guidelines Advocate Use of Two New Therapies Las Directrices Europeas y Norteamericanas sobre Insuficiencia Cardíaca Abogan por el Uso de 2 Nuevos Tratamientos

US and European Heart Failure Guidelines Advocate Use of Two New Therapies

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Vagus Nerve Stimulation Fails to Improve Clinical Outcomes in Chronic Heart Failure

Heart Failure Still a Problem but Less of a Burden on Acute MI Patients

黑人NSTEMI患者的长期死亡率比白人患者差，这与治疗差异有关系

Long-term Mortality Worse for Black vs White NSTEMI Patients, Linked with Treatment Discrepancies

La Mortalidad a Largo Plazo es Peor en Pacientes NSTEMI de Raza Negra que en Pacientes de Raza Blanca con Discrepancias en el Tratamiento

Landmark IMPROVE HF Trial Shows Evidence-Based Programs Result in Improvements in Heart Failure Patients Regardless of Race, and Improves Survival

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content